HK-based PE firm PAG acquires 58% stake in Hisun BioRay for $540m

HK-based PE firm PAG acquires 58% stake in Hisun BioRay for $540m

Photo from Hisun Pharmaceutical's website.

Mars W. Mosqueda Jr.

05 September, 2019

Hisun BioRay PAG

Printed by Unregistered user on Mon, 13 Apr 2026 08:08:11 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

[Updated] HK's PAG to raise over $2b for eighth opportunistic realty fund

Chinese drug developer I-Mab Biopharma said to file for US IPO

Read more from Greater China

Chinese AI startup StepFun to unwind offshore structure ahead of IPO

Ping An taps secondaries market again for $1b fund stakes: reports